Opening book details…
About this book
Author Correction: Inhibition of lysine acetyltransferase KAT6 in ER+HER2- metastatic breast cancer: a phase 1 trial by Toru Mukohara & Yeon Hee Park & David Sommerhalder & Kan Yonemori & Erika Hamilton & Sung-Bae Kim & Jee Hyun Kim & Hiroji Iwata & Toshinari Yamashita & Rachel M. Layman & Monica Mita & Timothy Clay & Yee Soo Chae & Catherine Oakman & Fengting Yan & Gun... is a book available to read on EtoBox.
- Author
- Toru Mukohara & Yeon Hee Park & David Sommerhalder & Kan Yonemori & Erika Hamilton & Sung-Bae Kim & Jee Hyun Kim & Hiroji Iwata & Toshinari Yamashita & Rachel M. Layman & Monica Mita & Timothy Clay & Yee Soo Chae & Catherine Oakman & Fengting Yan & Gun...
- Publisher
- Springer US
- Published
- 2024
- Language
- EN
More by Toru Mukohara & Yeon Hee Park & David Sommerhalder & Kan Yonemori & Erika Hamilton & Sung-Bae Kim & Jee Hyun Kim & Hiroji Iwata & Toshinari Yamashita & Rachel M. Layman & Monica Mita & Timothy Clay & Yee Soo Chae & Catherine Oakman & Fengting Yan & Gun...
Similar books
- Tucatinib and Trastuzumab in HER2-mutated Metastatic Breast Cancer: a Phase 2 Basket Trial — Alicia F. C. Okines & Giuseppe Curigliano & Nobumasa Mizuno & Do-Youn Oh & Andree Rorive & Hatem Soliman & Shunji Takahashi & Tanios Bekaii-Saab & Mark E. Burkard & Ki Y. Chung & Philip R. Debruyne & Jenny R. Fox & Valentina Gambardella & Marta... (2025)
- Sacituzumab Govitecan in HR+HER2- Metastatic Breast Cancer: the Randomized Phase 3 EVER-132-002 Trial — Binghe Xu & Shusen Wang & Min Yan & Joohyuk Sohn & Wei Li & Jinhai Tang & Xiaojia Wang & Ying Wang & Seock-Ah Im & Dongdong Jiang & Theresa Valdez & Anandaroop Dasgupta & Yiran Zhang & Yilin Yan & Kimberly M. Komatsubara & Wei-Pang Chung & Fei Ma &... (2024)
- Trastuzumab Deruxtecan in Metastatic Breast Cancer with Variable HER2 Expression: the Phase 2 DAISY Trial — Fernanda Mosele & Elise Deluche & Amelie Lusque & Loïc Le Bescond & Thomas Filleron & Yoann Pradat & Agnes Ducoulombier & Barbara Pistilli & Thomas Bachelot & Frederic Viret & Christelle Levy & Nicolas Signolle & Alexia Alfaro & Diep T. N. Tran &... (2023)
- Metronomic Chemotherapy Plus anti-PD-1 in Metastatic Breast Cancer: a Bayesian Adaptive Randomized Phase 2 Trial — Hongnan Mo & Yongpei Yu & Xiaoying Sun & Hewei Ge & Lanlan Yu & Xiuwen Guan & Jingtong Zhai & Aihua Zhu & Yuhan Wei & Jinjing Wang & Xiaoyan Yan & Haili Qian & Binghe Xu & Fei Ma (2024)
- Sacituzumab Tirumotecan in Previously Treated Metastatic Triple-negative Breast Cancer: a Randomized Phase 3 Trial — Yongmei Yin & Ying Fan & Quchang Ouyang & Lihua Song & Xiaojia Wang & Wei Li & Man Li & Xi Yan & Shusen Wang & Tao Sun & Yuee Teng & Xianjun Tang & Zhongsheng Tong & Zhengkui Sun & Junyou Ge & Xiaoping Jin & Yina Diao & Gesha Liu & Binghe Xu (2025)
- Trastuzumab Deruxtecan Versus Trastuzumab Emtansine in HER2-positive Metastatic Breast Cancer: Long-term Survival Analysis of the DESTINY-Breast03 Trial — Javier Cortés & Sara A. Hurvitz & Seock-Ah Im & Hiroji Iwata & Giuseppe Curigliano & Sung-Bae Kim & Joanne W. Y. Chiu & Jose L. Pedrini & Wei Li & Kan Yonemori & Giampaolo Bianchini & Sherene Loi & Giuliano S. Borges & Xian Wang & Thomas Bachelot &... (2024)